Alyeska Investment Group
CANO

Alyeska Investment Group’s Cano Health, Inc. CANO Stock Holding History

Alyeska Investment Group’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-20,000
Closed -$21.5M – 835
2021
Q2 		$21.5M Buy
+20,000
New +$27M 0.25% 120
2021
Q1 		– Sell
-7,026
Closed -$9.42M – 861
2020
Q4 		$9.42M Sell
7,026
-7,556
-52% -$8.64M 0.13% 203
2020
Q3 		$15.2M Buy
+14,582
New +$15.2M 0.23% 136

Other funds holding CANO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Alyeska Investment Group's CANO Position: Q3 2021 in Review

Alyeska Investment Group sold out of Cano Health, Inc. (CANO) in Q3 2021, closing a stake of 20,000 shares — an estimated $21.5M sold.

Alyeska Investment Group first reported a position in CANO in Q3 2020 and held it in 3 quarters. The position peaked at $21.5M in Q2 2021. 110 funds tracked by Wall St. Rank hold CANO as of Q3 2021.

  • Alyeska Investment Group reported no remaining Cano Health, Inc. position as of Q3 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 20,000 Cano Health, Inc. shares in Q3 2021, an estimated $21.5M.
  • Alyeska Investment Group first reported a position in Cano Health, Inc. in Q3 2020 and held it in 3 quarters.
  • Alyeska Investment Group's Cano Health, Inc. position peaked at $21.5M in Q2 2021.
  • 110 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q3 2021.

Based on Alyeska Investment Group's 13F filing for Q3 2021, filed 15 Nov 2021.